rs2908004 — WNT16 Gly82Arg

WNT16 Gly82Arg — A Missense Variant That Weakens Cortical Bone

Your bones are constantly being broken down and rebuilt. At the heart of that process in cortical bone¹¹ cortical bone
the dense outer shell that forms 80% of the skeleton and provides most of its mechanical strength sits the WNT16 protein — a signaling molecule secreted by bone-forming cells that keeps bone-resorbing cells in check. The rs2908004 variant introduces a single amino acid change (glycine to arginine at position 82) in WNT16 that impairs this regulatory function. Carriers of the G allele at this position tend toward thinner cortical bone, lower bone mineral density at fracture-prone sites, and elevated lifetime fracture risk. Unlike the neighboring intronic variant rs3801387 that influences WNT16 expression levels, rs2908004 directly alters the WNT16 protein structure.

The Mechanism

WNT16 is expressed predominantly by osteoblasts — bone-forming cells lining cortical bone surfaces²² expressed predominantly by osteoblasts — bone-forming cells lining cortical bone surfaces. It suppresses osteoclast (bone-resorbing cell) formation through two parallel pathways: directly inhibiting osteoclast progenitor differentiation via a non-canonical Wnt pathway³³ non-canonical Wnt pathway
a signaling branch independent of the classic beta-catenin cascade, and indirectly through upregulating osteoprotegerin (OPG) — a decoy receptor for the osteoclast-activating signal RANKL. The net effect is preserved cortical thickness and reduced endocortical porosity.

The Gly82Arg substitution replaces a small, flexible glycine residue with a bulky, positively-charged arginine at position 82 in the WNT16 protein. Glycine residues at structural turning points in proteins are often critical for proper folding; their replacement frequently alters protein conformation and interaction with binding partners. Position 82 lies within the cysteine-rich domain (CRD)⁴⁴ cysteine-rich domain (CRD)
the domain responsible for binding to WNT receptors (Frizzled family) and co-receptors; essential for signal transduction, the functional core of WNT ligands. Disrupting CRD geometry is a well-documented mechanism by which WNT family missense variants reduce signaling activity, consistent with the observed association between the G allele and lower BMD.

The Evidence

The definitive evidence for rs2908004 comes from a landmark GWAS meta-analysis by Zheng et al. (2012)⁵⁵ landmark GWAS meta-analysis by Zheng et al. (2012) spanning 5,878 European subjects across multiple cohorts. The G allele at rs2908004 was associated with a −0.16 SD reduction in forearm BMD per allele (P = 1.2×10⁻¹⁵ — far exceeding genome-wide significance thresholds). Forearm BMD reflects cortical bone at the distal radius, one of the most common fragility fracture sites. The same study found a forearm fracture OR of 1.22 per G allele (P = 4.9×10⁻⁶).

García-Ibarbia et al. (2013)⁶⁶ García-Ibarbia et al. (2013) studied 1,083 Spanish individuals and found rs2908004 associated with femoral neck BMD (average difference 35 mg/cm²; p = 0.00037), calcaneal ultrasound parameters (p = 0.00004), and femoral neck buckling ratio (p = 0.0007) — a geometric measure of fracture susceptibility. Among individuals under 80 years old, protective genotypes were significantly underrepresented in hip fracture patients (OR 0.50 for the protective genotype).

Age of study matters: Correa-Rodríguez et al. (2016)⁷⁷ Correa-Rodríguez et al. (2016) demonstrated that rs2908004 influences broadband ultrasound attenuation (BUA)⁸⁸ broadband ultrasound attenuation (BUA)
a quantitative ultrasound parameter that measures bone density and microarchitecture at the heel without radiation exposure even in young adults (mean age 20, n=575; p = 0.001). This positions the variant as a determinant of peak bone mass acquisition, not just age-related bone loss — making early intervention particularly meaningful.

The largest population study, the Taiwan Biobank analysis (Wu et al. 2022)⁹⁹ Taiwan Biobank analysis (Wu et al. 2022) with 10,942 participants, confirmed a 35% lower osteoporosis risk in those with GA or AA genotypes compared to GG (OR 0.651; 95% CI 0.544–0.780). Importantly, the interaction between rs2908004 genotype and BMI was statistically significant (p = 0.0148), with underweight GG individuals facing particularly elevated risk (OR 7.66 vs normal-weight GG).

Practical Actions

The consistent finding across European and East Asian populations is that the G allele impairs WNT16-mediated osteoclast suppression, translating to thinner cortical bone and higher fracture risk at the wrist, hip, and other cortical-dominant sites. The effect operates additively: two copies of G confer the most risk, one copy intermediate risk, and AA (no G) offers the best genetic protection.

For GG individuals, building and protecting cortical bone requires active intervention. The two most evidence-backed strategies are ensuring adequate calcium (1,000–1,200 mg/day) and vitamin D (supporting levels of 30–60 ng/mL), combined with mechanical loading via weight-bearing exercise, which stimulates periosteal bone apposition — the cortical-specific growth mechanism most relevant to WNT16 function. For those under 30, the priority is maximizing peak bone mass; for those older, minimizing cortical bone loss rate.

The interaction with underweight status (BMI interaction p = 0.0148) is clinically meaningful: GG individuals who are underweight face compounded risk. Low body weight accelerates cortical bone loss through reduced mechanical load and lower estrogen/androgen levels — exactly the pathways WNT16 impairment already compromises.

Interactions

Rs2908004 is in high linkage disequilibrium with rs3801387 (intronic, regulatory) and rs2707466 (another missense variant, Thr>Ile), which together form a WNT16 haplotype block spanning 7q31.31¹⁰¹⁰ WNT16 haplotype block spanning 7q31.31. These variants partially tag each other, but rs2908004 captures the coding-level impact directly. The Zheng 2012 analysis showed both missense variants contributing to the cortical bone signal, with rs2707466 showing the stronger cortical thickness association and rs2908004 stronger for forearm BMD.

WNT16 function intersects with the broader WNT signaling architecture including LRP5 (co-receptor) and SOST (sclerostin — a WNT inhibitor). Individuals with risk variants in both WNT16 and LRP5 may face compounded cortical bone deficits. Separately, the BMI interaction (Wu et al. 2022) suggests WNT16 genotype modifies how body composition affects bone health — providing a precision lens on dietary and exercise counseling that goes beyond standard advice.